Your browser doesn't support javascript.
loading
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors.
Chapman, Daniel; Judge, Parminder K; Sardell, Rebecca J; Staplin, Natalie; Arnold, Thomas; Zhu, Doreen; Ng, Sarah; Moffat, Stewart; Landray, Martin J; Baigent, Colin; Hill, Michael; Haynes, Richard; Clark, Sarah; Herrington, William G.
Afiliação
  • Chapman D; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Judge PK; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Sardell RJ; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Staplin N; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Arnold T; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Zhu D; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Ng S; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Moffat S; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Landray MJ; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Baigent C; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Hill M; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Haynes R; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Clark S; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Herrington WG; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Medical Research Council-Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: will.her
Kidney Int ; 103(4): 787-790, 2023 04.
Article em En | MEDLINE | ID: mdl-36736537

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glicosúria Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Kidney Int Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glicosúria Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Kidney Int Ano de publicação: 2023 Tipo de documento: Article